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ABSTRACT

Suture-Less Trocar Site Closure for Postoperative Hernia Prevention following
Laparoscopic Surgery
Hares Patel, Dr. Daniel Metzinger, Dakota Waldecker and Dr. Robert S. Keynton
Introduction: Following laparoscopic surgery, there is a need, in many cases, to close
trocar sites to prevent hernias. Currently, devices that exist on the market are suture
based, but the lack of standardization in the suturing techniques together with the timeconsuming nature of the procedure leads to the need for improvement in trocar site
closure products. Trocar closure sites do not need to be fully closed on the fascial layer;
rather, sufficiently blocking the hole at the abdominal wall can significantly reduce postoperative herniation. A retrospective study on trocar site herniation (TSH) after
laparoscopic surgery indicates a TSH incidence of ~5.2% out of a total of 30,568 adult
and 1,098 child procedures [7]. Specifically, trocar sizes greater than 10mm, failure to
suture the fascia, and fast absorbable suture were found to be linked to TSH. Thus, the
purpose of this study is to present a new, rapid deployment, biodegradable device for
trocar site closures.
Methods: The Trocar Site Closure Clip (TSCC) is a biodegradable clip to be inserted
into the abdominal cavity through a 12mm trocar and retracted to pierce into the
peritoneum and fascia. The TSCC will be inserted via an applicator through the trocar to
the abdominal cavity. The trocar will be extracted from the patient. The TSCC will be
pulled upward into the peritoneum and fascia. The applicator will be released leaving the
v

TSCC to be separated and left in the patient to seal the trocar site. The TSCC is
composed of polylactic acid and tested in various manufacturing modifications for
optimization. TSCC prototypes completed bench top testing in dragon skin silicone,
porcine belly, cadaver, and in a chronic swine model study.
Results: The results of this study demonstrate proof of concept for a biodegradable trocar
site closure clip as a potential solution as a reliable trocar site closing and postoperative
hernia prevention device in laparoscopic surgery. This study shows that the
biocompatible poly-lactic acid-based device can plug and seal 12mm trocar site openings
along with in animal peritoneal tissue.
Conclusion: This study successfully fabricated biocompatible TSCC prototypes using
commercially-available manufacturing techniques. This study demonstrated the efficacy
of the TSCC to be inserted into/through a trocar and engage the abdominal wall to plug
the hole and prevent postoperative herniation.
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NOMENCLATURE
TSH – Trocar Site Herniation
MIS – Minimally Invasive Surgery
LAP – Laparoscopic
TSCC – Trocar Site Closure Clip
Insertion Force – The peak force required to pass the device into the trocar
Delivery Force – The peak force required to insert the device into the medium
Retraction Force – The peak force withstood in attempts to dislodge the device out of the
medium with a vertical force
CAD – Computer Aided Design
Tm – Melting Temperature
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I. INTRODUCTION
Currently, there is a need for effective/efficient trocar site closure especially with
the rise of LAP surgeries to be performed with more surgeons becoming specialized,
increasing technical capabilities of LAP surgery, and incentives such as lower
hospitalization time or decreases risk of infection. The development of a rapidly
deployed, reliable device will result in safer and faster LAP surgeries. Due to the need of
a simple alternative that surgeons can rely on, a revised suture-less device was prototyped
at the University of Louisville. The proposed design is inserted into the proximal end of
the trocar, travels through to the distal end of the trocar to the abdominal wall where
clinching arms will grip the ends of the separated tissue. The clinician will tug on the
device applicator to deliver the device into the separated tissue, constricting the wound
from opening and reducing the possibility of postoperative herniation. To conclude the
procedure, the operator will rotate the device and snap it off the applicator. The device
will be left implanted in the cavity to degrade as the wound heals.
1.2

Purpose of the Study
The purpose of this study is to continue the work off the previous student’s

fabrication of the device, update the manufacturing process, and verify that the newly
designed trocar clip successfully closes a trocar site opening from a trocar greater than
10mm in both a cadaver and an animal.
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1.3

Hypothesis
Laser cut trocar site closure devices fabricated with less than 100% fill and

sharpened tips will require less insertion and delivery force compared to 3D printed
trocar site closure devices.
1.4

Significance of the Study
The significance of this study is that it will develop a fast method to close trocar

site wounds by minimizing the amount of time a surgeon will take in suturing the wound
closed. This device is expected to decrease the incidence of TSH and evolve the current
capabilities of laparoscopic surgery.

2

II. LITERATURE REVIEW
2.1

Clinical Problem
Minimally invasive surgery (MIS) is a modern surgical technique in which

surgery is performed via 0.5-1.5cm incisions in the abdominal, pelvic, or chest cavity
(Figure 1). The cavity is inflated with carbon dioxide gas and illuminated with a
laparoscopic camera. Surgery is executed by the insertion of tools into the anatomical
opening monitored by the camera. The most evident advantages for patients of MIS
include: minimized trauma to the abdominal wall, faster convalescence, reduced hospital
stay, faster return to normal activity, decreased post-operative pain, reduced risk of
hemorrhaging, and reduced exposure of internal organs. MIS has continuously developed
and advanced from a minimally invasive diagnostic tool to an efficient instrument for
surgical treatment of benign and malignant diseases. The ongoing training, experience,
and development in imaging and laparoscopic instruments have facilitated extension of
the applications of laparoscopic surgery. The outcome, efficiency, decreased incidence of
wound infections, and reduced perioperative morbidity of minimally invasive procedures
have been shown across different applications, e.g., appendectomy, cholecystectomy,
esophageal surgery, reflux surgery, gastric surgery, colorectal surgery, colon cancer,
rectal surgery, rectal cancer, liver surgery, pancreatic surgery, splenectomy, hernia repair,
and adrenalectomy [6]
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Figure 1: Depiction of laparoscopic tools being used in a MIS procedure within the abdominal cavity. [19]

The MIS technique has attained progressive global popularity over time with
complex procedures. In 2013, there were 2.5 million MIS/laparoscopic (LAP) surgical
procedures performed in the U.S. alone. The ports utilized to insert surgical instruments
into the inflated cavity in laparoscopic surgery are called trocars. Being the only access
point for surgeons, trocars are an essential component for LAP surgery.
The use of trocars in LAP surgery have several benefits for the patient, however,
also present a risk of developing trocar site herniation post-operatively. A hernia is the
bulging of an organ from an abnormal opening in the body, visually depicted in Figure 2.
Post-operative herniation caused by trocar site is the bulging of an organ into the opened
tissue site from the retracted trocar. A retrospective study on trocar site herniation (TSH)
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after laparoscopic surgery published in 2011 indicates from a total analysis of 30,568
adult procedures and 1,098 child procedures, an incidence of TSH of 0-5.2% [7]. 96% of
TSH resulted from a trocar diameter of 10mm or greater and 82% of the TSH cases
occurred in the umbilicus region. Blunt/cutting trocars, trocar type, procedure specificity
was not found to be related to TSH. Trocar sizes greater than 10mm, failure to suture the
fascia, fast absorbable suture was found to be linked to TSH. In addition to TSH,
ineffective trocar suturing can be cumbersome and adds time to the surgical procedure,
can be intricate, inaccurate, and requires several operators.

Figure 2: Anatomical depiction of an inguinal hernia.[20]

2.2

Trocar Site Closure Methods
LAP procedures are increasingly popular in modern medicine. However, even

with the benefits of LAP surgery, there are technical challenges of properly closing the
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trocar wound site. Trocar openings dilating the fascial wound to 10mm in adults and
5mm in children are to be closed, incorporating the peritoneum into the fascial closure, to
prevent the risk of hernia formation. Closure of these wounds are difficult and not always
complete due to the small opening of the skin incision. Standard techniques can be
difficult and frustrating, often involving a blind closure of the fascial defect [9]. Several
techniques have been developed to facilitate this fascial closure. These techniques vary
from delivery systems, binding systems, application procedures, and visualization
techniques. Due to the variety in trocar site closure techniques, each method presents its
own pros and cons. The sections that follow describe a compilation of trocar site closure
techniques developed by modern medicine.
2.1.1

Maciol Needles
Maciol needles (Figure 3) are a set of three needles used to close a trocar site: a

straight needle, curved needle, and a retriever needle. The straight and curved needles are
fed through the abdominal wall into the peritoneal cavity with the suture. The retriever
needle is inserted into the peritoneal cavity from the other side of the trocar site. Once the
suture is collected by the retriever needle, the suture is pulled through the tissue under
direct laparoscopic visualization. The suture is tied within the subcutaneous tissue that
incorporates the fascia and peritoneum. The suture is inspected before the exclusion of
the trocar. This procedure does not require any enlargement of the skin incision.
Contarini et al., studied this closure technique (Core Dynamics Inc., Jacksonville, FL) for
three years without the reoccurrence of trocar hernia [1].
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Figure 3: Graphics of Maciol suture in use.[1]

2.1.2

Grice Needle
The Grice needle technique includes the passing of one needle from opposite

sides of the trocar site (Figure 4). First, the Grice needle is inserted at an angle along the
side of a lateral trocar. Second the suture is passed through the fascia and peritoneum
cavity. Under direct laparoscopic visualization, the suture is grasped via a surgical
instrument in an opposite trocar and pulled out of the cavity. The Grice needle is removed
and reinserted at an angle at the opposite of the trocar to be closed. The suture is grasped
again and pulled out of the cavity. The trocar is then removed from the patient. The
suture is tied with added tension placed on the site to prevent the loss of carbon dioxide
(CO2). Stringer et al. studied this technique (Ideas for Medicine Inc., Clearwater, FL) to
close 80 lateral trocar sites [2].
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Figure 4: Graphics of Grice needles in use.[2]

2.1.3

Vein Catheter/Spinal Needle
The technique using vein catheters and spinal needles for suture placement was

developed after Earle et al and Petrakis et al found a technique for closure with an opolypropylene suture applied in a purse-string manner using a 15-gauge spinal cord
needle (Figure 5). First, a nonabsorbable o-polypropylene suture is inserted with the use
of a 15-gauge spinal needle 0.5 to 1 cm from the trocar site around the umbilical opening
at a 45-degree angle, creating a purse string. The first needle is inserted with the suture
and Endo GraspTM forceps (Medtronic, Minneapolis, MN) are used to pull the free suture
edge into the abdomen. The needle holding the suture is reinserted at the next point and
the free intra-abdominal edge of the suture is locked through the loop that had been
created. This step is repeated three times to correctly orient the purse string. Lastly, the
suture edge is pulled, and the needle is withdrawn outside the abdomen near the site of
the first needle insertion, and both edges of the suture are tied up onto the fascia. This
procedure was studied by Petrakis et al., however, the researchers commented “that this

8

method is not suitable for large abdominal wall defects, complicated hernias, recurrent
hernias, or routine use to repair anterior abdominal wall defects.” [2]

Figure 5: Graphics of Vein Catheter (left) and Spinal Needle (right). [2]

2.1.4

Endo Close Suture Device
The Endo CloseTM suture device (Medtronic, Minneapolis, MN) is a spring-

loaded suture carrier (Figure 6). The common technique with this device involves the
loading of an o-absorbable suture. The suture is introduced to the abdominal cavity
between the edge of the skin and the port via the Endo Close after which the device is
removed. The Endo Close is the then injected between the edge of the skin and the port
opposite to the initial insertion. The suture is reloaded into the Endo Close and the device
and suture are withdrawn out of the abdomen. The trocar is removed, then the fascia and
peritoneum are tied to close the tissue.
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Figure 6: Graphic of the Endo CloseTM suture device in use.[2]

2.1.5

Gore-Tex Suture Passer
The Gore-Tex suture passer (W.L. Gore & Associates, Phoenix, AZ) is like the

Endo Close suture carrier, being a method of inserting and removing a suture from the
abdominal cavity, but different because it is a reusable device (Figure 7). The Gore-Tex
device is first loaded with suture and inserted into the abdominal cavity through the
subcutaneous tissue and fascia on the side of the trocar to be closed (the trocar is still in
place). The laparoscope is used to view the trocar site to be closed visualizing the
peritoneal cavity. The suture is released from the grasper by pushing down the handle and
removed from the cavity. The device is reinserted on the opposite side of the initial
insertion. The suture is located, placed into the suture passer with the use of graspers in a
surround trocar, and locked into position by retracting the handle. The suture is removed
from the cavity by pulling the suture passer out. Lastly, the trocar is removed, and the
suture is tied down [2].
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Figure 7: Depiction of the Gore-Tex Suture Passer in use. [2]

2.1.6

Carter-Thomason Device
The Carter-Thompson CloseSure System (Cooper Surgical, Trumbull, CT)

consists of two components: the Pilot guide and the Carter-Thomason suture passer
(Figure 8). Closure of the incision requires four easy steps. The first step includes using
the suture passer to push suture material through the pilot guide, fascia, muscle,
peritoneum, and into the abdominal cavity. The second step is to push the CarterThomason device through the opposite side of the Pilot guide and pick up the suture. The
third step is to pull the suture up through the peritoneum, muscle, fascia, and guide. The
fourth step is to remove the Pilot guide and tie the suture. For bariatric and obese patients,
Carter-Thomason device comes in an extra-long length with a lengthened pilot guide to
reach the peritoneum layer and provide full-thickness closure. Elashry et al. studied the
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the CloseSure system and found that it is the fastest trocar wound closure system
(~11mins) when compared to the Endo Close device and Maciol needles [2].

Figure 8: Depiction of how to use the Carter-Thomason device in use. [2]

2.1.7

Endo-Judge
The Endo-JudgeTM (Synergistic Medical Technologies, Inc., Orlando, Florida)

wound closure device is a 14-gauge hollow J-shaped needle that serves as a carrier for
suture material and a device for performing the fascial closure (Figure 9). The suture is
mounted on a reel at the proximal end of the device and fed to the hollow needle until it
is delivered out the needle tip. The plastic oval shield (olive) at the J portion of the needle
maintains pneumoperitoneum (keeps the pressure steady in the abdomen) and prevents
injury to underlaying organs. The instrument is then positioned in a plane perpendicular
to the trocar incision to expose the needle and pass it through the peritoneum and fascia
12

until it exits the skin incision. The end of the suture is grasped and tagged with a
hemostat. The needle is dropped back into the olive and rotated to the opposite side. The
needle is once again passed through the peritoneum and fascia via the olive. After
removal of the Endo-Judge, the suture is tied creating a secure, airtight fascial and
peritoneal closure. This device is used under direct visualization. [2]

Figure 9: Step-by-step graphics of how to use the Endo Judge wound closure. [2]

2.1.8

Tahoe Surgical Instrument Ligature Device
The Tahoe surgical instrument ligature device (Tahoe Surgical Instruments (San

Juan, PR) includes a handle with a locking button, one hollow metal needle for delivery
and one hollow metal needle for retrieval of the suture (both ports are 2 cm apart) (Figure
10). To use this device, first the laparoscopic cannula needs to be removed. Next the
suture is loaded into the hollow delivery Tahoe needle without extension beyond the
distal end of the needle. The device is introduced into the abdomen proceeding the
insertion of two holes on the introduction disk. The needle tips are then guided to pierce
the fascia on one side of the trocar site. Releasing the lock allows the handle to depress
until the metal retrieval loop is extended and encompasses the tip and distal shaft of the
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delivery needle. The suture is fed into the delivery needle until it lies several inches
beyond the distal end of the delivery needle and through the retrieval loop. After the
handle is released allowing the retrieval loop to retract, the entire device is withdrawn
from the port site. The suture is tied by the surgeon joining the peritoneum and fascia. [2]

Figure 10: Graphic of Tahoe Surgical Instrument Ligature Device. [2]

2.1.9

eXit Disposable Puncture Closure Device
The eXit disposable puncture closure device (Progressive Medical, St. Louis,

MO) is a 10-mm instrument with a recessed right-angle needle manually articulated from
the proximal end of the device (Figure 11). Due to the size of the device, this instrument
can only be used in 12-mm trocar ports. The device is inserted into a 12-mm trocar port
and then needle is exposed for puncture. From the abdominal cavity, the needle is pulled
up through the fascia and peritoneum. The skin is pulled away from the tip of the needle
to avoid puncture of the skin. Once the needle is located out of the peritoneum and fascia,
it is loaded with o-absorbable suture. The device is pushed back through the port of the
abdomen with the suture. Once in the peritoneum cavity the eXit device is articulated to
14

the opposite side of the trocar. The needle is then pulled up delivering the suture through
the peritoneum and fascia. The needle is identified, and the suture is pulled out of the
device. The device is removed from the port, the trocar is removed from the site, and the
suture is tied closing the post site. [2]

Figure 11: Graphic of eXit Disposable Punture Closure device in use. [2]

2.1.10 Suture Carrier
The suture carrier is a hooked device custom designed to maximize vertical space
when accessing a trocar site for closure (Figure 12). The suture carrier is comprised of a
hook retractor with an eye drilled into the tip through which suture material can be
threaded. The instrument designed by Jorge et al. and Li and Chung is 24 cm long has an
end effector CT needle designed by Ethicon Endo-Surgery. The procedure in using a
suture carrier starts with lifting the fascial edge vertically with the hook retractor and
piercing the suture carrier into the peritoneum and fascia of the wound. The suture
material is threaded into the exposed eye of the carrier. Next, the suture carrier is pulled
back into the abdominal cavity and pierced through the opposite side of the trocar wound
site. The suture is collected and tied after the carrier is taken out of the patient. The trocar
must be removed from the patient before you can perform this procedure. [3]
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Figure 12: Graphic of the Suture carrier device in use.[3]

2.1.11 Lowsley Retractor with Hand Closure
The Lowsley retractor (Circon ACMI, Stanford, CT) with hand closure is a device
for trocar site closure for wounds created by 12mm trocars (Figure 13). The Lowsley
retractor is closed and slid into the intended trocar to the abdominal cavity. Next, the
blades of the Lowsley device are opened and the trocar is removed from the patient. With
the retractor still in the abdominal cavity and the blades splayed, the Lowsley retractor is
pulled upward tilting the fascia towards the skin. A standard hand suture is then
performed to close the trocar wound site.
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Figure 13: Graphic of the Lowsley Retractor with Hand Closure in use.[2]

2.3 Intellectual Property
A search of US Patents and Patent Applications using the terms “closure” AND
“trocar” and “bio-absorbable” results in a group of 1000 matches. Another advanced
search was conducted with the terms “trocar” AND “site” AND “closure” resulting in
three matches. Below is a compilation of patents that propose a solution to the problem
statement indicated in this study. The University of Louisville Research Foundation has
secured a patent on a trocar site closure assembly reserving the intellectual property
(shown at the bottom of Table 1 this study will build on.
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Table 1: Table representing the hits for intellectual property search.
Patent Applications
20120316594

20110251638

8323312
20120022586
20110144661

6939356

9451950

9463019

Title
Apparatus for closing
an opening, such as a
trocar opening, in a
patient’s body
Implantable
biodegradable wound
closure device and
method
Closure device
Tissue closure device
and method
Tissue closure
devices, device and
systems for delivery,
kits and methods
therefor
Medical instrument
for closure of trocar
site openings and
method for use of
same
Apparatus and
method for fascial
closure device for
laparoscopic trocar
port site and surgery
Trocar site closure
assembly

Assignee
Mount Sinai School of
Medicine

Pub. Date
12/13/2012

Strategic Capital, LLC

4/11/2010

Abbott Laboratories
Micro Interventional
Devices, Inc.
CardioVascular
Technologies, Inc.

12/04/2012
1/26/2012

Elle G. Debbas

9/06/2005

Manoj B. Patel, Philip
Zhao, Neal Patel,
Landon Gilkey, David
M. Albania, Salvatore
Castro
University of
Louisville Research
Foundation, Inc.

9/27/2016

6/16/2011

10/11/2016

2.4 Literature Review Conclusion
Following laparoscopic surgery, there is a need in many cases to close the trocar
sites to prevent hernias. Currently, devices that exist on the market are suture based. Lack
of standardization of suturing techniques, time consuming nature of the procedure, and
many different techniques to close trocar sites leads to an availability to improve closure
of trocar sites. Trocar closure sites do not need to be fully closed on the fascial layer, but
simply blocked at the site where the trocar penetrated the abdominal wall. By sufficiently
blocking the created opening, post-operative herniation can be significantly reduced.
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There are complex devices on the market that claim to close trocar incision sites,
and there are suture techniques that are accepted to seal trocar wounds with cumbersome
procedures. However, there is yet to be a novel device that combines an easy to use
device with the reliability to prevent post-operative herniation consistently. In addition, in
terms of in the realm of intellectual property, there are several opportunities to be
explored.
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III. METHODS & PROCEDURES
3.1

Device Characteristics

3.1.1

Specifications
The device design is a suture-less device that can be inserted through a trocar and

then engaged into the tissue to block and at least partially close the wound site. Figure 15
through Figure 20 depicts a progressive conceptual example of a standard delivery
mechanism for this clip device. The device will be deployed by advancing it through the
trocar and possesses a flexible design so that the device can compress as it passes through
the trocar. Once the suture-less device clears the bottom of the trocar, the arms spring
back (or expand) to its original, non-deformed shape, the device is then pulled up into the
muscle layer through the peritoneal layer. This device has two arms that engage the
tissue. Each arm has anywhere from 1 to multiple barbs (2, 3, etc) on either or both sides
of the arms to retain the device in the tissue while the wound heals. The device design
can include stress notches on each of the arms to strengthen the device during delivery
and insertion into the tissue. The device design can include retraction ribs on the outside
of the arms to increase the retention strength of the clip. Figure 17 and Figure 18 depict
the deformed and non-deformed state of the closure clip, respectively. This design is a Uor V-shaped to allow the arms to be flexible enough to deform through the trocar, and
durable enough to withstand delivery forces. The tips and/or sides of the arms are
sharpened to allow the device to tear through the peritoneal and muscle layers, reduce the
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effects of tissue compliance, minimize the generation of a moment force on the device to
prevent rotation during delivery, and facilitate the delivery of the device. The angular
design of the barbs prevents dislocation of the device by gripping the tissue to prevent
motion of the device post delivery. The devices are made of biodegradable material that
will degrade as the patient heals. The porosity of the material (infill) may vary to
decrease the rate of material biodegradation. The tool used to insert and deliver the trocar
site closure clip can be unique to the trocar clip design or universal to fit in all endoscopic
forceps. The release of the trocar site closure clip can be by torqueing, manually
releasing, or snapping off the trocar site closure clip of the delivery tool. Figure 14
depicts a CAD model of a potential trocar site closure clip.

Figure 14: Solidworks Model renderings of the laser-cut device (left) and Post-processed device (right).

3.1.2

Device Delivery Concept

The order of operation for deploying the device is illustrated in Figure 15 through Figure
20, and includes the following steps:
1. Insertion of distal end of device into the proximal end of the trocar.
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2. Application of axial force on the device, compressing the arms of the trocar site
closure clip into the trocar.
3. Passing of the clip through the trocar into the abdominal cavity.
4. Rebound of the clip arms to the original uncompressed/non-deformed span.
5. Removal of the trocar from the patient.
6. Retraction and delivery of the trocar site closure clip to plug the trocar opening.
7. Snap or manual release of the trocar site closure clip from the delivery device.

Figure 15: Insertion of the distal end of the TSCC into the proximal end of the trocar.
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Figure 16: Passing of the clip through the trocar into the abdominal cavity.

Figure 17: Removal of the trocar from the abdomen of the cavity.
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Figure 18: Retraction and delivery of the TSCC to plug the trocar opening.

Figure 19: Remnant of device after the TSCC stem is snapped/broken off and excised.
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Figure 20: Bottom view of plugged trocar site.

3.2

Device Manufacturing Processes

3.2.1

Design Analysis of Distal Stem
A five design DOE was conducted with various end effectors and distal designs to

optimize the distal design of the device to ability minimize the insertion force and
deformation through the trocar and minimize the required force and device deformation
during delivery (piercing) into the tissue. Five solid model configurations of the distal
design were created in computer aided design (CAD) software (SolidWorks, Dassault
Systèmes, Waltham, MA) using varying angles, notches, and narrowness (Figure 21 and
Figure 22). Two thicknesses of the ABS devices (1/8” and 1/16”) were used for
comparison. A full factorial study with three factors (design, thickness, and tube
delivery), factors levels at five designs, two thicknesses and two tube delivery methods,
along with three replicates requires a total of 60 data points. A random run order was
utilized to account for device variance. Devices were constrained by an applicator at the
two holes in the proximal stem of the device.
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Figure 21: Different end effector designs for final design selection of ABS TSCC.

Figure 22: CAD model of Design 3.

3.2.1.1 Laser Cutter Configuration
The solid CAD model designs were transferred to an image to (Adobe Illustrator,
For Web and Interactive Design, Ventura CA) cut the design onto a sheet of material. For
cost effectiveness, the design study was conducted on acrylonitrile butadiene styrene
(ABS), a material that is similar in tensile properties to PLA, but cheaper and easier to
obtain. Devices were laser cut on a BOSS laser cutter (model: LS1630, BOSS Laser,
LLC, Sanford, FL, Figure 22) and labeled for testing. For cutting, the laser cutter was
programmed to cut at 20mm/s at 20% power. The laser was passed twice over the ABS
sheets to ensure a clean cut of the devices. Figure 24 through Figure 29 show the general
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workflow for fabricating the ABS test devices: 1) 36in by 12in sheet of ABS was placed
in the laser cutter; 2) 60 devices were cut with the laser at the operating parameters stated
above; and, 3) finished cut devices were removed from the laser cutter, separated and
packaged based on the design and thickness of the devices.

Figure 23: Laser Cutter used for device preparation.

Figure 24: ABS Sheet laid in laser cutter.
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Figure 25: ABS devices being cut from ABS sheet by laser cutter.

Figure 26: Finished printed TSCC from laser cutter.
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Figure 27: Finished 1/8” devices packaged and ready for testing.

Figure 28: Device applicator (top) and secured TSCC in device applicator (bottom).
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Trocar Seal
cap was
removed prior
to device
insertion.

Figure 29: Line up of TSCC and proximal end of Trocar prior to testing.

The tube delivery method describes the fixtures that were used to insert and
deliver the devices and the speed at which the devices were delivered into the tissue. The
two speeds (tube delivery) used in this study were 1in/min and 2 in/min.
Devices will follow the order of operation described in 3.1.3 until delivery of the
device onto an acrylic plate. The devices will not be tested for retraction force or the
force to separate the distal end of the device from the proximal stem. A fixture was
designed to orient and stabilize a 12mm trocar and allow a vertical path for the load
frame.
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3.2.2

Initial Device Manufacturing Process
The manufacturing process of this device started with the fused filament (3D)

printing of the material. The material used in the cadaver studies was an Ecomax® PLA
(polylactic acid) biodegradable co-polymer (3DXTech, Grand Rapids, MI) using 100%
virgin PLA biopolymer resin and colorants. A M2 Makerbot (MarkForged, Brooklyn,
NY) fused deposition modeling (FDM) printer was used to extrude an 1/8” plate of PLA
to fit four devices. The PLA was printed using 100% infill which ensures a solid device.
The pre-sharpened device CAD design was downloaded and then laser cut (BOSS LS1630) in the PLA sheet printed in the fused filament printer using the same operating
parameters as described above for the ABS devices. The pre-sharpened devices were then
sharpened in a custom guillotine fixture (Figure 30).

Figure 30: Process for further sharpening the tips of the device arms (left to right).

3.2.2.1 Guillotine Sharpening Method
Devices were placed in the bottom half of the fixture and a razor was placed in the
top half of the fixture to create a “guillotine” type tool. The bottom half and top half of
the sharpening fixture were aligned by dowel pins to drop the “guillotine” at the same
location every time. The top half of the fixture was then pressed onto the TSCC mounted
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in the bottom half of the fixture to cut angled corners off the TSCC arms. Once, one side
of the device arm was cut, the device was flipped and cut again using the same process
described above leaving sharpened tips on the device arm.
3.2.3

Modified Device/Delivery Concept
The original device delivery concept was modified from a torsional, snap-off

release concept to the utilization of a separate tool to manually release the device after
being delivered into tissue. Figure 31 illustrates the modified device delivery process
utilizing the separate tool to deliver and release the TSCC device. This separate tool
should have a long shaft length of 8in and a diameter of less than 10 mm. The tip of this
tool should have a pattern on the ed effector to initiate some sort of grip on the device.

Figure 31: Schematic illustrating the insertion of the trocar into the abdominal cavity.
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Figure 32: Schematic illustrating the compression of the device as it translates through the trocar.

Figure 33: Schematic for illustrating the steps for removal of the trocar and retraction of the device into the
fascia to plug the trocar site opening.
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Figure 34: Schematic illustrating the release of the TSCC into the abdominal cavity to obstruct the opening.

3.2.3.1 Final Device Manufacturing/Delivery Process:
1/8” thick sheet of PLA

Figure 35: Laser cut devices (right) from FDM printed sheets (left) of PLA.
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Razor blade cutting
device tip

Figure 36: Schematic illustrating the guillotine fixture for sharpening tips of the new device arms.

Figure 37: Image of the Dremel tool (left) used to taper the arms of the device (right).
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Figure 38: Image of device arms sanded with P220 grade sand paper for smooth finishing.

Concentration of heat
on device stem

Figure 39: Images of the heating and stamping of the device stem to fix device into the endoscopic forceps.
Top left: heat gun; Top right: heating of the device stem; Bottom: final device placed in endoscope forceps.
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Sharpened to be normal to tissue

Figure 40: Final sharpening with grade P1600 sand paper of device arms: Top left: before
sanding; Top right: sanding process; and, Bottom: finished device.
The manufacturing process ( Figure 35 through Figure 40Error! Reference
source not found.) of the final TSCC device started similarly to the previous method,
that is, 100% virgin Ecomax® PLA biopolymer resin and colorants were used to 3D
print extrude an 1/8” plate of PLA using the M2 Makerbot FDM printer. However, this
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time the PLA was printed using 95% infill. The pre-sharpened device CAD design was
downloaded and then laser cut (BOSS LS-1630) from the printed PLA sheet using the
same operating parameters as defined above (20mm/s at 20% power). The pre-sharpened
devices were inserted into the custom guillotine fixture to sharpen the tips of the device
arms. The device arms were then tapered with a Dremel tool (Dremel Tools, Racine,
WA) to give a triangular shape – the sharpened tip of the devices was maintained during
this step. Subsequently, the arms were sanded down with two different grades of
sandpaper (220-grade and 1600 grade) to decrease the surface roughness. After the
device arms were sanded down to a smooth finish, the stem of the device was heated
(using a heat gun Atten Instruments, 85OB) and the end effector pattern of the
endoscopic forceps was stamped onto the stem of the device. A nozzle was used on the
end of the heat gun to concentrate the heat on the stem of the TSCC. The heat gun was set
to a temperature of 310 ºF and a blow setting of 4. The heat gun was passed over the stem
at a distance of 1 inch from the TSCC device surface, twice. After stamping the devices,
they were submerged in a beaker of cold water to set the mold of the TSCC design.
Lastly, the 1600 grit sandpaper (3M) was used to give a vertical point to the device to
improve the piercing ability of the TSCC device for tissue penetration (Figure 40). It is
noted that the manufacturing process of the prototypes was constrained due to the
availability of tools. This process could be greatly enhanced using more sophisticated
manufacturing processes, such as injection molding, and a custom sharpening device that
yields the final desired tip sharpness.
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3.3

Benchtop Studies

3.3.1

Materials Testing System Set-up
A materials testing system (MTS, MtestQuatro, Norwood, MA) was used to

measure the vertical forces exerted on the device as it is lowered into the trocar and as the
device is pulled upward to be delivered into the tissue (Figure 42). Measurements of the
insertion force and delivery force will be recorded as peak values by the MTS. The MTS
was programmed with a data sampling rate of 100 Hz and recorded both the position and
load force as a function to time. 100Hz was calculated using the Nyquist theory of
sampling. To accurately plot the data it was estimated that 50 data points per second of
load frame movement would be needed. Nyquist theory states that the frequency used to
measure should be 2x Fmax. Therefore 100 Hz was used to plot the data points. 100 lbf
load cell was used to accurately measure the tensile forces. Devices were lowered and
raised at a rate of 1in/min and 2 in/min to the desired distance to pass through the trocar
and penetrate through the medium being tested. In this case, the medium being tested was
chicken breast tissue. The chicken breasts were held down with the equal displacement of
the normal force. Figure 41 shows the set-up of the load frame with the mount used to
orient and stabilize the trocar. The chicken breasts were held in place by Plexiglas®
around the edges. The Plexiglas® was constrained to the mount by clamps/screws.
Screenshots of the MtestQuatro software is in the appendix section 6.1.
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the trocar.
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breast while delivering the
device.

Figure 41: Image of the MTS load frame set-up used for testing the TSCC devices.

3.3.2

PLA Material/Printer Study
The purpose of this test is to compare PLA materials/printer settings to determine

the difference in PLA prototype performance to be used in animal and cadaver studies.
The two PLA filaments compared in this study are: 1) the PLA devices used by Dakota
Waldecker (my predecessor) in his cadaver studies; and, 2) the PLA devices used in this
study on cadavers. It was necessary to test this change in PLA manufacturing because the
printer and filament used in the previous studies were no longer be available for this
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work. Therefore, a new PLA filament and printer was compared to the previous PLA
devices to determine any differences in PLA peak failure points and assess whether there
were significant differences between the two prototypes. In this study, two PLA types
were compared in their ability to withstand a tensile force on the arms of the device. A
total of nine devices were tested from each manufacturing system.
The PLA devices used in the Cadaver Lab 1 studies were printed at Advanced
Solutions Inc. using a M2 MakerGear FDM printer (Beachwood, OH). The devices used
in this study were 100% infill in a 45° rectilinear pattern with a first layer extrusion
temperature of 215°F and 210°F for the subsequent layers. The bed temperature for the
first layer was 65°F and 60°F for the subsequent layers. The program used to splice the
design was a Repetier-Host (version 1.2.9, BoXYZ, Pittsburgh, PA). Screen shots of the
PLA printer settings can be found in the appendix section 6.2 of this document.
A dowel pin inserted through the proximal slot of the device stem constrained the
device to the load frame. The load frame depicted in Figure 42 shows the fixture that
holds the dowel pin in place while the load frame pulls the device upward. TSCC devices
were compared by the peak tensile force that plastically deformed the device in tension.
The two materials were tested to determine if there was a statistical difference in the
material properties between the two materials used. Laser cutting of the devices followed
the parameters in 3.2.2 on the PLA sheets. The load frame set up followed the
parameters described in 3.3.1. The load frame head speed was 2 in/min for the upward
motion of the device.

41

Figure 42: Test set-up for peak tensile force (constrained by dowel pin).

Figure 43: Before (left) and after (right) tensile force applied to determine plastic deformation peak force.

3.3.3

Infill Study
In this study, device infill was adjusted to increase the ductility of material to

increase the flexibility of the device and decrease the force required to insert device into
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the trocar. In addition, it was predicted that decreasing the infill and having a more
porous PLA device would decrease the time for biodegradation and create pockets for
tissue integration. The stiffness of the initial design created stress marks at the notches
indicating that compression of the arms plastically deformed the device (Figure 44) and
led to device failure during delivery of the device into the medium.

Figure 44: Depiction of the plastic deformation at the distal end from insertion into the trocar. Arrows
indicate sites of stress and eventual failure of the devices.

Devices were altered to have 70%, 80%, 90%, and 100% infill during the FDM
printing process of the PLA sheets. This alteration was intended to increase the flexibility
of the device arms upon insertion into the trocar. The same FDM printer settings as
referenced in appendix 6.2 were used, but the infill of the PLA sheets was changed to
70%, 80%, 90%, and 100%. The laser cutter and load frame settings were the same as
referenced in the testing of the devices for study 3.2.2 and 3.3.1
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Figure 45: Images of the PLA sheet cut-outs for the varying infill settings
(top left: 70%, top right: 80%, bottom left: 90%, bottom right: 100%).

A design of experiments was created with 1 factor, 4 levels, 3 replicates, and 2
responses. The 4 levels to the infill factor were 70%, 80%, 90%, and 100% and the two
responses were insertion force and delivery force. The responses were utilized to create a
linear regression analysis for the optimal device infill. Comparisons were conducted in
random order fashion to account for the variability of the testing procedure. Devices were
inserted into a 12mm trocar to simulate the trocar that the device will be inserted during
the cadaver lab. Devices were retracted into the Plexiglas® platform similar to the
delivery test conducted in 3.2.2 with the same insertion rate and data acquisition settings.
Figure 46 depicts the test fixture set-up for testing (similar to the testing conducted for
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the design and material study 3.2.1 and 3.3.2, respectively). The devices were constrained
by two set screws at the proximal stem.

Figure 46: Test Set-up for PLA infill study.

3.3.4

Sharpening and Acetone Study
This study was conducted to mitigate proximal stem stress deformation upon

insertion into a trocar and the problem of high delivery force required to penetrate tissue.
Device sharpening was required for the penetration of the device into the fascia of the
tissue. A blunt tip on the arms of the device increases the force required to penetrate
tissue and increase the force on the arms of the device. Therefore, a fixture was created to
sharpen the arm tips on the devices to improve tissue penetration and relieve the force on
the device arms.
In addition, devices were treated in acetone to increase the flexibility of the device
arms for easier insertion into the trocar. It is a known technique to rub acetone on PLA
FDM printed part to soften the material. In this study, acetone was used to soften the
device arms for increased flexibility.
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The purpose of this study was to test the sharping fixture and the acetone
treatment for effectiveness in device insertion and device penetration.
The tissue models used in this study will include the Dragon Skin silicone and
Chicken thigh. Silicone materials have been used to simulate tissue biomechanics as
related to deep tissue injury [12]. Chicken thigh was used because of its use in the design
study: section 3.2.1.
This study included a three factor DOE with two factor levels, and 12 replicates.
Using the data from the previous studies, power analysis estimated that 12 replicates
would be needed to achieve a power greater than 90%. The responses recorded included
insertion force and delivery force.
•

•

•

Sharpening
o

Sharpened

o

Not Sharpened

InFill Pattern
o

95% Rectilinear (Acetone Treatment)

o

95% Rectilinear (No Acetone Treatment)

Tissue Model
o

Dragon Skin

o

Chicken

PLA with 95% infill was used in this study because of its positive results from the
infill testing (referenced in section 4.2.1). Device manufacturing followed the same steps
outlined in study 3.2.2 in terms of device PLA printing and laser cutting. Device were
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then treated with a drop of acetone at the arms of the device as pictured in Figure 47 then
left overnight to dry.

Figure 47: Drops of acetone on arms of the device to soften the PLA material.

Following laser cutting, devices were sharpened by the fixture depicted in Figure
36. Dimensions of the sharpening fixture can be found in Appendix section 6.3.
3.3.4.1 Application Fixture
The application device in Figure 48 was created for cadaver testing. The
aluminum applicator has tapped hole at the proximal end that is compatible with a handheld force gauge. The distal end of the device mimics the proximal shape of the device so
that the device can be constrained. The distal holes were tapped to allow set screws to
hold the TSCC in place. Dimensions of the applicator can be found in the Appendix
section 6.4. Dragon skin silicone was cut to have an incision large enough to fit the
trocar. The load frame mount to stabilize/orient the trocar was updated to be compatible
in constraining both dragon skin and chicken thigh (Figure 51 and Figure 52).
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Figure 48: Expanded view of application device and TSCC assembly.

Figure 49: Application device in upright stance.
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Figure 50: Small Incision made in Silicon for Trocar insertion.

Figure 51: Visual of test set-up before (top) and after (bottom) of trocar in and out of test fixture.

Load frame and device laser cutting were conducted as described in sections 3.3.1
and 3.2.2. The test fixture to constrain the tissue models followed the layout in study
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3.3.1. However, for this study, clamps were added to the second tier to constrain the
tissue models: chicken thigh and dragon skin silicon (Figure 52).

Tissue
Models
clamped to
this tier.

Figure 52: Devices sharpening and infill test fixture.

3.3.4.2 Dragon Skin Silicone Preparation:
The Dragon Skin Silicone was prepared to the specifications included in the
package. The dragon skin silicone utilized is the Smooth On: Dragon Skin Translucent
Platinum Silicone (Smooth On Inc., Macungie, PA). Figure 53 through Figure 56 show
the process used to set the dragon skin silicone evenly and to the same depth. Plastic petri
dishes were used for silicone setting. Each petri dished was filled to the same depth with
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the wet dragon skin silicone to ensure consistency between batches. The silicone discs
were cut into quarters for use in testing.

Figure 53: Separation of ingredients in two cups.

Figure 54: Weighing of mixture components (left and middle) and mixing of components in fume hood
(right).

Figure 55: Measurement of petri dishes and pouring silicone into petri dishes.
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Figure 56: Allowing the silicone to dry in petri dish before cutting the specimen into quarters.

3.3.5

Revised Device Application Study
In evaluation of the devices during the cadaver testing, there was a necessary

adjustment needing to be made to the design of the device. The applicator was updated to
another model requiring a more rigid structure and holding the device at a more distal
position. The new application device was planned to be used with an updated TSCC
design. To hold the TSCC at a more distal point, the stem of the device was taken off. In
addition, it was predicted that narrower arm stems would be needed to decrease the force
required to deliver the TSCC into tissue. Lastly, to fit the new application device,
Snowden-Pence lap tool, the TSCC were heated and stamped to merge the design of the
Snowden-Pence applicator end effector to the proximal end of the TSCC. Figure 31
through Figure 34 depict the updated manufacturing steps to create the TSCC.
The methods of this study consisted of functional trials using the device prototype
to plug trocar site sized incisions in dragon skin silicon and porcine belly. A full factorial
design was created with two factors (material treatment and tissue model), two levels,
with five replicates. The levels in this study included two different materials: PLA with
acetone dip or PLA without acetone dip and two different tissue models: dragon skin
silicone or porcine belly. Porcine belly squares prepared by a butcher was used in this
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study as the second tissue model (Kingsley Meat and Catering, Louisville, KY). The
porcine belly was positioned to be penetrated from the skin side to model, being a more
rigid surface to penetrate. PLA devices were treated with acetone like the acetone treated
devices in 3.3.4. The dragon skin silicone was prepared as described in section 3.3.4.2.
The responses test in this study were the insertion force (the peak force required
to pass the device into the trocar, the delivery force (the peak force required to insert the
device into the medium), and the retention force (the peak force withstood in attempts to
dislodge the device out of the medium). The same load frame set-up was used from study
3.3.4 with the same sampling rate and load frame insertion/delivery rates. However,
instead of using clamps to constrain the tissue model as performed in 3.3.4, a new
Plexiglas® plate was used to constrain the tissue model. This change was made to
simulate a more diffused surface force when holding the tissue models in place (shown in
Figure 59). From this study the best prototype will be selected and utilized in another
cadaver lab to prove efficacy of the design. Cadaver lab was conducted in the Fresh tissue
lab at the University of Louisville Medical School with Dr. Daniel Metzinger.

53

Figure 57: Acetone treated devices drying.

Figure 58: Preparation and thawing of frozen porcine belly squares.
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Plexiglass plate pressed
onto tissue to secure in
place during device
delivery.

Figure 59: Delivery of updated TSCC devices into porcine belly squares.

3.4

Cadaver Studies

3.4.1

Cadaver 1 Study
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm

trocar wounds in a cadaver. Cadaver tissue is to be an indicator of the effectiveness of the
TSCC to penetrate living tissue. This study is an indicator of whether the TSCC is ready
for further testing in chronic animal testing. Cadaver tissue is known to be less elastic
than live tissue, so the cadaver tissue is meant to simulate a scenario that is harder to
penetrate.
The cadaver was ordered through the University of Louisville Bioengineering
department. The study was conducted at the University of Louisville School of Medicine
in the fresh tissue lab. During this study the force to insert the TSCC and deliver the
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TSCC was measured with a hand-held tensile force gauge and a custom application
device shown in Figure 60.

Figure 60: The attachment of the applicator to the hand-held force gauge.

The updated and current design for the TSCC was compared to the past TSCC
that were created in previous studies. The goal of the testing to demonstrate an
improvement from the previous cadaver testing to show a decrease in force required to
insert the TSCC into the trocar and the force required to deliver the TSCC into the tissue
when compared to the previous design. Six of the previous devices were used in the study
and six of the newly developed prototypes were tested in this study. The newly developed
devices in this study were the 95% infill with acetone, sharpened devices tested in 3.3.4.
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3.4.2

Cadaver 2 Study
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm

trocar wounds in a cadaver. Cadaver tissue is to be an indicator of the effectiveness of the
TSCC to penetrate living tissue. This study is an indicator of whether the TSCC is ready
for further testing in chronic animal testing. Cadaver tissue is known to be less elastic
than live tissue, so the cadaver tissue is meant to simulate a scenario that is harder to
penetrate.
The cadaver was ordered through the University of Louisville bioengineering
department. The study was conducted at the University of Louisville School of Medicine
in the fresh tissue lab. During this study the force to insert the TSCC and deliver the
TSCC was measured with a hand-held tensile force gauge and a custom application
device.
This study was like the study conducted in 3.4.1 in terms of device preparation
and the programing of the load frame. However, a new updated TSCC design was
utilized as tested in 3.3.5. In this cadaver study a two factor DOE was conducted with
two factor levels, and four replicates. The factors in this study was either a one barb
design or a two-barb design, and if the TSCC devices were treated in acetone or not
treated in acetone. Devices were inserted with the new application device as tested in
3.3.6. The hand-held force gauge was attached to the new applicator using the clamp in
Figure 63.
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Figure 61: Snowden-Pence Lap Tool Applicator.

Figure 62: Clamp placed onto Snowden-Pence Lap Tool.

Figure 63: Attachment of clamp to hand-held force gauge depicting entire set-up for cadaver testing.
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3.5

Short Chronic Animal Study

3.5.1

IACUC Proposal Methods
The purpose of this study is to evaluate the ability of TSCC in sealing a 12mm

trocar wounds and to analyze the healing progression of tissue around the inserted device.
For this study three 60kg pigs were ordered and tested under local anesthesia in the RRC
at the University of Louisville hospital at different times. The IACUC test proposal can
be found in the Appendix section 6.5 including the proposed test procedure, anesthesia
protocol, and (pain management) protocol. The tested pigs were kept alive for seven days
prior to euthanasian. Porcine tissue is to be an indicator of the effectiveness of the TSCC
to penetrate living tissue and predictive of healing progression around the device in
human tissue. This study is meant to provide proof of concept for the TSCC in effectively
plugging, sealing trocar wounds, and preventing postoperative herniation. The animals
were ordered through the University of Louisville bioengineering department. The study
was conducted at the University of Louisville RRC along with help from trained IACUC
veterinarians and technicians. During this study the force to insert the TSCC and deliver
the TSCC was not measured with a hand-held tensile force gauge. The main objective of
this study was to examine the healing progression of the TSCC device in a living model.
In this study, the sharpened, no acetone dip, one barb TSCC design was utilized
as tested in 3.5.1. Due to the success of the one barb TSCC design in cadaver lab 2, and
since retention force was not going to be measured, there was no need to test more than
one TSCC design. A total of six trocar incisions were created in each pig and six devices
were delivered in each pig. Devices were inserted with the new application device,
Axillent Lap Tool (Karl Storz, Tuttlingen, Germany), tested in 3.4.2. The only difference
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of this applicator is the distal grip design and proximal release mechanism. This change
was to make testing easier for the surgeon. All the pigs were not tested on the same day
and each pig did not receive TSCC from the same batch. A new batch of devices were
created for each pig study. TSCC was sterilized prior to testing via ETO sterilization at
the RRC. Before the chronic animal trials were conducted, test trials were prepared with a
recycled rabbit carcass from another study. The rabbit was euthanized just before this
trial run and a couple of TSCC devices were delivered into the tissue without any issues.
Figure 64 through Figure 66 show images from this trial test setup.

Figure 64: Trial of TSCC on Rabbit Carcass with Axillent Karl Storz Lap Tool Applicator.
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Figure 65: Picture of abdominal wall from the outside of carcass after device was inserted.

Figure 66: After closing the trocar wound with TSCC device in trial carcass.

3.5.2

Histology Preparation
Seven days after the procedure, the animals were euthanized, and the trocar sites

were harvested and set in formaldehyde. The harvested devices were shipped to Mass
Histology in Worcester, MA for histology of the trocar sites. All sites, whether they were
successfully plugged, or open wounds were sent for histology. The services requested
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include slide preparation from tissue equally spaced from the axis of the trocar wound,
trichrome staining, a semi-qualitative report analyzing for newly formed collagen fibers,
and annotated photography showing new collagen formation of tissue near implanted
device in container. The goal of the histology was to help analyze/compare the presence
of new collagen fibers near the incision site, the implanted device, around the healing
wound, and to get an impression of the device biocompatibility in an animal.
A 2017 publication studying The Biodegradation and Biocompatibility of Poly Llactic Acid (PLLA) implantable Mesh performed an in vitro and in vivo 180-day
evaluation of alterations in weight, tensile strength, inflammatory response. The study
found that “the weight and tensile strength of the PLLA prosthesis was stable for 180
days. In addition, the surface of the PLLA mesh was not digested under in vitro or in vivo
conditions as determined by scanning electron microscope. Histologically, there were no
significant changes in the diameters of implanted PLLA mesh and subtype fibers over the
course of 180 days. Likewise, there were no significant changes in the number of
inflammatory and mast cells after 180 days, nor was there an increase in the percentage
of collagen surrounding the PLLA mesh” [13]. Results indicated that PLLA mesh did not
induce inflammation in subcutaneous tissue; however, according to other literature, may
induce inflammation in different tissues or under specific incubation conditions. The goal
is for this study’s histological findings to determine the biocompatibility of PLA (from
this study) in peritoneal tissue.
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IV. RESULTS AND DISSCUSSION
4.1

Design Results

4.1.1

Device Distal Stem Design Results
This study was conducted to determine the distal end effector design that is most

effective for parameters laid out for the TSCC in Section 3.1. The goal was to find the
distal design that requires the lowest insertion force and the design that can withstand the
highest delivery force. The results of this study show that there were significant
differences between the designs and thicknesses during the insertion of the devices into
the 12mm trocar, but no significant difference caused by the interactions of the factors, as
seen in Figure 67. The main effects were plotted for insertion forces of the devices and
designs 1, 2, 3, 4, 5 had an average insertion force of 2.06lbs, 2.84lbs, 1.65lbs, 1.79lbs,
and 2.29lbs respectively. The Tukey pairwise comparisons are shown in Figure 69. From
the Tukey pairwise comparison it can be determined that designs 2 and 5 had a
significantly higher insertion force and designs 1, 4, 3, had a significantly lower insertion
force also shown by the main effects plot in Figure 68. Thickness of 1/16” had an average
insertion force of 1.66lbs, and thickness of 1/8” had an insertion force of 2.600lbs.
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Figure 67: Analysis of Variance in Insertion Force.

Figure 68: Main Effects Plot of Insertion Force.
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Figure 69: Tukey Pairwise Comparison of Insertion Force.

In addition, the results of this study show that there were significant differences in
delivery force caused by the thickness of the designs and by the interactions between the
design, thickness, and tube delivery system as seen in Figure 70. The delivery force
interaction plot in Figure 71 shows that devices with a thickness of 1/8” can withstand a
significantly higher delivery force. The delivery forces for designs 1, 2, 3, 4, 5 at
thickness of 1/8” and tube delivery 1 had an average of 17.24lbs, 15.94lbs, 34.70lbs,
29.30lbs, 18.32lbs respectively. The Tukey pairwise comparisons are shown in Figure 72.
From that chart it can be determined which group of devices had the highest delivery
forces under which interactions. It is also shown that for designs 4, 1, and 5, the tube
delivery method did not have a significant effect on delivery force. High delivery force
means that the design can withstand more force and is a more superior design compared
to the others. This can be emphasized by the fact that the design changes are only
applicable to the end effectors and not the device arms.
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Figure 70: Analysis of Variance of Delivery Force.

Figure 71: Interaction Plot of Delivery Force.
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Figure 72: Tukey Pairwise Comparison of Delivery Force.

To distinguish the most effective design for the purposes of this application, a
decision matrix was created as seen in Table 2. This decision matrix was used to rank the
TSCC designs by their insertion force averages, delivery force averages, and the ease of
testing. The delivery force averages were weighted higher than the insertion force, and
the insertion force averages were weighted higher than the ease of testing. Each category
of the decision matrix was given a number to rank its performance in testing. The higher
the number, the more desired the result. In this case, lower insertion forces were desired
and higher delivery forces were desired. The tube delivery 2 was more preferred than
tube delivery 1 because of the less time required in testing. The distal design of device 4
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led to showing that the design was capable to withstand the highest delivery force while
minimizing the force required to insert the device into the trocar. The other distal designs
did not show this trend to the extent that design for did. After totaling the results, design
4 at 1/8” was selected to be used in further studies.
Table 2: Decision Matrix for Optimal End Effector TSCC Design.

4.1.2

Dakota Prototype Material Study
Summaries for the results of the two devices tested can be found in Figure 73 and

Figure 74. For the results of this study a non-normal, Kruskal Wallis test (Figure 75)
performed after unsuccessful attempts to transform the non-normal data from both
materials. The transformation used include: sqrt(t); 1/sqrt(1); ln(y); log10(y). In
comparison of the two PLA materials, the ECOMAX PLA and the PLA material used by
the previous student differed in their peak tensile forces. The average peak break force of
the Advanced Solution devices was 24.9lbs (Figure 73) and the average peak break force
of the ECOMAX devices was 20.62lbs (Figure 74). Even though the testing shows that
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there is a significant difference in the peak forces of these two PLA materials, the
ECOMAX devices are still an applicable choice. The ECOMAX devices having a
maximum peak load of 20.62lbs should be more than enough for the requirement of our
devices. For clinical circumstances, the devices should need no more than 10lbs force for
the device to be delivered into tissue. Since the ECOMAX devices had a peak force of
two times what should be necessary, it can be considered a viable candidate for
prototyping.

Figure 73: Summary of Advanced Solutions Devices.
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Figure 74: Summary of ECOMAX devices.

Figure 75: Kruskal-Wallis Test for Material Study.

4.2

Benchtop Studies Results

4.2.1

Infill Study
The goal of this study was to optimize the infill percentage of the devices to have

the most effective insertion forces while not compromising the delivery force tensile
strength. The 70%, 80%, and 90% devices broke upon insertion into the trocar. The
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devices were too fragile to make it into the trocar without fracturing inside. Figure 76
shows the failure of a device after insertion into a trocar.

Figure 76: Fracture of the left? device arm.

The 100% infill devices were the only devices that made it through the trocar
intact, however, the devices had stress notches on the distal end. The devices were
compromised by the stress notches and the delivery device force varied between runs.
Figure 78 and Figure 79 shows end of the delivery force test and the breakage of the
other infill devices. Due to the variability of the 100% devices and the failure of the 70%,
80%, 90% devices failed during insertion, a linear regression couldn’t be made.
Therefore, a fifth infill percentage was created and tested at 95% infill. Figure 77 shows
the results for testing with the 95% infill. Tensile forces for 70%, 80%, and 90% are the
tensile break forces. The 95% infill devices didn’t always show signs of stress notches
forming on the distal end due to the compression of the device arms when passing
through the trocar. The delivery force of the 95% devices were more consistent and
showed less sign of device stress.
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Infill Results Bar Chart
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Figure 77: Bar Plot of Insertion Force and Delivery Force in PLA Infill Study.

Figure 78: Device failure of 80% Infill Device Upon Insertion into Trocar.
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Figure 79: Device Tensile Force Break Point Testing.

4.2.2

Sharpening and Acetone Study
The results of the benchtop study comparing acetone treatment to non-acetone

treatment along with a comparison of tissue models are shown as a Bar plot in Figure 80.
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Sharp v. Acetone Results Bar Chart
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Figure 80: Bar Plot from Benchtop Testing of Acetone/Non-Acetone treated devices in both tissue models.

In the bar plot in Figure 80, the Acetone 1 refers to devices that did have the
acetone treatment, and Acetone 2 refers to devices that did not have the acetone
treatment. Tissue model 1 refers to delivery of the devices into the dragon silicone, and
Tissue model 2 refers to delivery of the devices into the chicken thigh. The devices that
were not treated with acetone plastically deformed during insertion into the trocar and
were compromised before being delivered into the tissue model. Due to this, the nonacetone treated devices never pierced the silicone and the arms snapped off. The acetone
treated devices had a lower insertion force than the non-acetone devices. During
insertion, the acetone treated devices were able to flex and did not fracture during
insertion into the trocar. The allowed the acetone treated devices to remain intact and
maintain the structural integrity pierce through the silicone. Both the non-treated and
treated devices were able to pierce the chicken thigh. Due to these results, the acetone
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treated devices were selected to be used in the cadaver lab. Averages for the benchtop
testing are labeled in Figure 80. Pictures from testing are shown in Figure 81 through
Figure 84.

Figure 81: Acetone treated devices piercing the dragon skin silicone during testing.

Figure 82: Underneath view of the TSCC successfully penetrating chicken thigh.
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Figure 83: Front view of the bench top testing.

Figure 84: Devices laid out prior to testing.

4.2.3

Revised Device Application Study
In this study, both acetone-treated and non-acetone treated, were evaluated in

dragon skin silicone and porcine belly, respectively. The non-acetone treated PLA
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devices required an average of 2.7lbs insertion force to pass into the trocar, and a 6.46lbs
delivery force to pierce into dragon skin and an 8.67lbs delivery force to pierce into the
porcine belly (Figure 86 and Figure 87). The acetone treated PLA devices failed during
the delivery process into both the dragon skin and porcine belly tissue models with an
average failure force of 5.76lbs and 9.7lbs, respectively. Therefore, only the non-acetone
treated PLA devices were used in the cadaver lab to prove the efficacy of the devices.
Figure 87 and Figure 88 show the failure of an acetone device failing in dragon skin
silicone and a successful non-acetone device penetrating porcine belly, respectively. The
acetone dip for these devices made the material too fragile to penetrate the tissue models
effectively. The narrowed device design for these prototypes proved to be effective in
naturally allowing the device arms to flex through the trocar without acetone treatment.
Revised Design: No Acetone Treatment
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Figure 85: No Acetone Treatment Devices Plot of Insertion Force and Delivery Force.
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Revised Design: Acetone Treatment
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Figure 86: Acetone Devices Plot of Insertion Force and Delivery Force.

Figure 87: Broken Acetone treated device during delivery into dragon skin silicone.
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Figure 88: Successful delivery of non-acetone treated device into porcine belly.

4.3

Cadaver Studies Results

4.3.1

Cadaver 1 Study
Cadaver 1 Results
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Figure 89: Bar Plot of Insertion Force and Delivery Force for "Previous" and "Hares” Devices.
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The devices labeled “Hares” in this study corresponded to the device that were
made with the most updated device design described in the methods of this study. The
devices labeled “Previous” correspond to the devices that were made by the previous
student. The “Hares” devices broke upon delivery into the cadaver tissue at an average
tensile force of 13.16lbs. The “Previous” devices had stress notches when passing
through the trocar and required an average of 7.34lbs. The “Previous” devices delivered
into the cadaver tissue required an average of 18.29lbs force to penetrate the tissue. The
insertion force for the “Hares” devices was an average of 5.31lbs lower to pass through
the trocar. The insertion force of the “Full devices was described as an acceptable amount
of force to apply when pushing a device into the trocar, per the surgeon. The surgeon also
mentioned that having a delivery force of 18.29lbs was too great for surgeons to perform
in live laparoscopic procedures. Figure 90 and Figure 91 show the delivery and insertion
of the “Previous” devices in the abdominal cavity.

Stress
notches from
passing
through
trocar.

Figure 90: Picture of the "Previous" Device in cadaver abdominal cavity before delivery.
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Figure 91: Delivery of the "Previous" device into cadaver tissue to plug trocar site.

After the “Hares” devices showed a consistent pattern of failure a new method
was attempted in delivering the TSCC device. Instead of pulling the device from the
proximal stem, a TSCC device was broken at the stem and a laparoscopic tool was used
to grip the device from the distal end as shown in Figure 92. The prototype device was
successful upon delivery into the cadaver tissue (Figure 93).

Figure 92: Hares devices (without stem) in cadaver abdominal cavity before delivery.
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Figure 93: Successful plug of trocar site with "Hares" devices without device stem.

4.3.2

Cadaver 2 Study
Ten devices were inserted into the abdominal cavity of a cadaver through a 12mm

car and delivered into the peritoneum and fascia. The trocar wound was successfully
plugged and sealed for potential hernia prevention (Figure 95 and Figure 96). Five of
each group were measured for insertion force and delivery force, and two from each
group were measured for retention force in the cadaver tissue. The average values
measured were 2.57lbs, 11.78lbs, 6.98 lbs, respectively (Figure 94). These devices
differed in their barb design. The one barb devices were more effective in delivering into
tissue because of the less resistance occurring on one barb device when compared to two
barb devices. The second barb on the two barb devices proved to be too much resistance
in some cases and led to device failure for 3/5 devices inserted. The bar chart shows the
tensile break point in this case. The great variability found in the measurement of the
82

retention force is likely due to the difficulty in measuring retention force in live tissue.
Pushing the devices out was hard to capture when the devices needed to be pushed into
the intestines of the animal.
Cadaver 2 Results Bar Chart
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Figure 94: Bar Plot of Insertion, Delivery, and Retention Force in Cadaver Lab.
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Figure 95: Successful Device Delivery into Cadaver Tissue.

Figure 96: Delivery of TSCC into Cadaver Tissue.

4.4

Short Chronic Animal Study Results

4.4.1

Animal Study Results
Three animal chronic animal studies were conducted at the RRC. Each of the

three pigs were kept alive for seven days before being euthanized. From the three
animals, Figure 97 shows the histogram of the surgery outcomes. In the first pig from the
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study, two surgeons took turns using the device. For consistency, for the second two pigs,
only one surgeon from the first study delivered the TSCC.

Pie Chart of Surgery Outcomes
Failed
3, 16.7%

Category
Failed
Good
One-Sided
Procedural Error

Procedural Error
8, 44.4%
Good
3, 16.7%

One-Sided
4, 22.2%

Figure 97: Pie Chart of Surgery Outcomes in Chronic Animal Study.

Three devices resulted in good successful plugs. Four devices had only one arm
pierce the tissue. Eight devices resulted in a procedural error when inserting/delivering
the device into the tissue. These procedural errors were classified as instances that the
device slipped during delivery into the tissue, the surgeon mentioned that “he/she didn’t
think they had applied enough force to deliver the device, or the device was jammed in
the device applicator after delivery and the surgeon had to break the device to free the
applicator. Three devices had a successful delivery. Figure 98 shows the outcomes from
necropsy.
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Pie Chart of Necropsy Outcomes
Category
Good Seal
Hernia
One-Sided
Open Wound

Good Seal
3, 16.7%

Hernia
1, 5.6%

Open Wound
10, 55.6%

One-Sided
4, 22.2%

Figure 98: Pie Chart of Necropsy Outcomes in Chronic Animal Study.

Three devices had successful retention in the tissue after seven days, four of them
resulted in just one arm stem remaining in tissue after seven days, ten trocar wounds were
open and did not have a device penetrating, and one trocar wound herniated displaying
the bulging of tissue through the open trocar wound. There weren’t hand-held force
gauge measurements during the animal trials. Therefore, it was difficult to determine the
force at which the devices failed to penetrate the pig tissue and the peak force that the
surgeon felt like he wasn’t pulling hard enough. This information would have been
necessary to perform further analysis of the devices that resulted in procedural errors
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during surgery. Figure 99 through Figure 103 show examples of the categories the
necropsy results were grouped in.

Figure 99: Example of Open Trocar Wound (was not properly plugged) Found in Necropsy.

Figure 100: Example of Herniated Trocar Wound Found in Necropsy.
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Figure 101: Example of Successful TSCC Found in Necropsy.

Figure 102: Example of TSCC That Only Had One Arm Penetrate Tissue Found in Necropsy.

Figure 103: Example of TSCC that had been encompassed by peritoneal tissue (Open Wound).
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4.4.2

Histological Findings
In the study, the harvested specimens from the animal study were shipped for

histology. The goal of histology was to qualify/compare the presence of new collagen
fibers near the incision site, the implanted device, healing around the wound, and get an
overall assessment of the biocompatibility of PLA devices in live tissue. Devices found in
the three pigs that displayed a good seal, hernia, one side penetration of the device,
biodegradation were sent in for histology along with one specimen from each animal that
recovered by normal healing and no tissue penetration (as a control). Figure 103 shows a
diagram from the list of instructions that were sent to histology for the preparation of
slides.

Figure 104: Diagram from Histology Instructions.

A total of 13 of the 18 collected specimens were sent for slide preparation with
trichrome blue staining. Five slides were prepared for each specimen at varying levels of
depth in the tissue. From the prepared slides a pathologist, analyzed the slides and
annotated the healing progression and the cellular findings. The pathologist was given
samples that did not have a trocar closure clip as controls (Figure 98) to compare the
histological findings.
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The samples submitted can be categorized to samples that had one arm of a device
penetrate and hold in the porcine tissue (Figure 102), had resulted in a herniation of
omental tissue (Figure 101), had been encompassed by the peritoneum (Figure 103), and
had a device that successfully plugged the trocar wound site (Figure 101). From the
samples that resulted in successful trocar wound closure, the pathologist wrote: “The
implant site demonstrates layers of muscle tissue and connective tissue with a core region
of collagen proliferation interspersed with neutrophils, macrophages and scattered
multinucleated giant cells. Deep in the tissue is a dense aggregation of collagen
interspersed with foreign material associated with multinucleated giant cells and
macrophages. The material in the multinucleated giant cells and macrophages is
interpreted as implant material that is undergoing phagocytosis. There are several foci
where the multinucleated cells with foreign material are outside the collagen
aggregation.” Later in his reports, the pathologist commented on that “there is no
suggestion of toxicity or infection in these sites” of all the sites altogether.
Figure 105 shows the slide of sample in which a device successfully plugged the
trocar closure site. From the slide, the pathologist notes that the “Granulation tissue and
fibrosis are stained blue with Masson's. The dark blue is likely existing connective tissue
stroma. The light blue is developing granulation tissue or fibrosis---this occurs during
healing.” Figure 106 shows the giant multinucleated cells and the implant material being
phagocytized.
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Figure 105: Picture of Slide from Pathologist.

Figure 106: High Power Image of Cellular Interaction with Degenerating Foreign Material.
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V. DISSCUSSION & CONCLUSION
The primary objective of this MEng thesis was to fabricate and validate a device
that proves the concept of using a biocompatible PLA clip to plug and seal a trocar
wound site preventing an opportunity for postoperative herniation.
The devices developed and tested in this study prove the concept that a PLA clip
can be used to plug and seal a 12mm trocar wound site preventing an opportunity for
postoperative herniation.
A testing of PLA devices in cadaver tissue show that the TSCC clips are flexible
enough to travel through a 12mm trocar without plastic deformation, can penetrate
cadaver tissue and plug a trocar wound, and are rigid enough to be retained in the tissue.
From chronic animal studies it is shown that the PLA device used in testing is
non-toxic and exhibits appropriate biocompatibility for the scope of this device. There are
factors that could have limited the results of this thesis. After the second design update of
the TSCC with a manual taper on the device arms, the repeatability and consistency of
the devices decreased. Without having a mold or machinery to shape the tapered design
of the TSCC, the results of the studies included an increased variability. Also, not having
a specifically designed applicator tool for the devices and having to manually stamp the
devices after re-heating the devices created an offset of the arms. The magnitude of this
offset could not be predicted and therefore, each TSCC had a vulnerable failure point on
one side of the device. While re-heating the stem of the device for stamping, the heat was
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not always concentrated onto the stem of the device, therefore, the device arms in some
cases were affected.
Due to the weight of the hand-held gauge along with the length and awkwardness
of the entire set-up, the measurements during cadaver lab sessions could have been
affected. In addition, the hand-held force gauge was creating an unorthodox way to
deliver the device into the abdominal wall. Due to the structured way devices were
benchtop tested with a load frame, the position in benchtop testing didn’t always correlate
to the position the device was delivered in the cadaver lab or pig. With the load frame the
device was always vertical and, in the cadaver/animal an organic torque was introduced
because of the natural curve of the abdominal cavity. This was unmeasurable during the
study.

Figure 107: Depiction of the torque generated by a non-perpendicular abdominal cavity.
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Lastly, the applicator was a limitation in this study. The applicators used in the
latter half of this study were existing laparoscopic tools. The TSCC devices had to be
deformed and manipulated to conform to the distal design and the grip of the lap tool
applicators compromising the integrity of the PLA. Also, the length of the applicators
was too long and awkward during device delivery creating torque on the device arms. If
the applicator was custom designed, these limitations created could have been mitigated.
In summary, a PLA trocar closure clip was used to plug and seal a 12mm trocar
wound preventing postoperative herniation. However, the design and manufacturing of
the device is critical along with the applicator used to deliver the device. From the results
obtained in the chronic animal trials, the theory of this proposal was validated. Although,
the results were not consistent, the concept of using plugging a trocar wound site closed
with a PLA clip was shown to be effective. Of the 11 open wounds from the chronic
animal trial, one open wound resulted in herniation of tissue. Post-operative herniation is
a legitimate risk that can be mitigated with proper blocking of the trocar site.
For the future of the work performed in this thesis, a couple recommendations can
be made. There is a need to design an injection mold for the updated designed TSCC
instead of using 3D printing. This method will decrease the amount of waste in the
manufacturing of the devices and will allow the PLA to be formed and then cooled into
the exact shape with the taper intended along with the proximal pattern so that the device
is compatible with the applicator. After the manufacturing steps for the TSCC are
completely mechanized, follow-up animal labs should be conducted to show efficacy of
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the manufacturing process and the TSCC. In addition, a custom applicator device should
be designed for the TSCC. This will deter users of the device from using their own
applicator with the TSCC which would minimize user errors. If the applicator is designed
specifically for the TSCC both can be testing in conjunction for efficacy. The critical
design components of the TSCC are the length of the shaft, distal grip design, and the
releasing mechanism of the applicator.
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